$PDM

Piedmont Realty Trust, Inc. to Report Third Quarter 2025 Financial Results

Atlanta, GA, Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Piedmont Realty Trust ( NYSE: PDM ) announced today that the Company will release its third quarter financial results on Monday, October 27, 2025, after the close of trading on the New York Stock Exchange.

Original reporting
GlobeNewswire · Piedmont Realty Trust, Inc.
Published Oct 7, 2025, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Oct 8, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Piedmont Realty Trust, Inc. to Report Third Quarter 2025 Financial Results — source image
Decision brief

The 30-second read

$PDMNeutralMed
01

Why it matters

Earnings reports can lead to increased trading volume and volatility, especially if results differ significantly from analyst expectations.

02

Market read

The upcoming earnings release is a key event for traders and investors in PDM, with potential short-term trading opportunities.

03

What to watch

Broader economic conditions and interest rate trends could overshadow company-specific news, influencing stock performance independently.

Timing: High, as the earnings report is scheduled for October 27, 2025.

Background

Piedmont Realty Trust is a publicly traded REIT with upcoming quarterly earnings scheduled for October 27, 2025.

Company-level read

Ticker impact

$PDMNeutralMedium confidence
Context

Primary focus due to company's upcoming earnings report.

Expected impact

Potential short-term increase or volatility around the earnings release; long-term impact uncertain.

Evidence & confidence

Earnings reports typically cause short-term price fluctuations. As this is an upcoming report, traders should monitor pre-earnings sentiment and technical levels.

Market effects

The real estate investment trust (REIT) sector may experience increased volatility, especially among peers reporting around the same period.

Limited regional impact; specific to the company's operations and investor base.

Low; the news pertains primarily to a US-based REIT and is unlikely to influence global markets.

Counterpoint

The earnings report may be in line with expectations, leading to minimal price movement, or even a short-term decline if results disappoint.

Key entities

  • Piedmont Realty Trust

    A real estate investment trust focused on commercial properties.

Related articles

$PDMMed

Piedmont Office Realty Trust, Inc. Q2 2026 Earnings Call Summary

Strategic Performance and Market Dynamics Management attributes the strong quarterly performance to a structural shift in the office market where demand is now outpacing the supply of high-quality, amenitized buildings. The company has successfully implemented asking rate increases of over 15% across a substantial portion of the portfolio, reflecting significant pricing power in core submarkets.

$PDMMed

Piedmont Realty Trust Q2 Earnings Call Highlights

Piedmont Realty Trust (PDM) reported Q2 earnings call highlights. Expansions totaled 9, adding 22,000 sq ft, with no contractions. Weighted average starting cash rent rose 5% to $43.79/sq ft. Net effective rent rose to $25.56/sq ft, over 20% above trailing 12-month. Same-store cash NOI grew 9% in Q2 and 10% in first half. Piedmont refinanced a term loan to $400M, extending maturity to May 2031.

$PDMMed

Piedmont Realty Trust: Q2 Earnings Snapshot

Piedmont Realty Trust (PDM) reported Q2 funds from operations of $47.9 million, or 38 cents per share, alongside a Q2 loss of $11.1 million, or 9 cents per share. The REIT said revenue was $144.1 million. It expects full-year funds from operations of $1.50 to $1.55 per share.

$PDMLow

Piedmont Realty Trust, Inc. (PDM): Results of Operations and Financial Condition

Piedmont Realty Trust, Inc. (PDM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pdm63026ex991q22026ersuppl.htm Q2 2026 EARNINGS RELEASE AND SUPPLEMENTAL PACKAGE Document EXHIBIT 99.1 Piedmont Realty Trust TM Earnings Release and Supplemental Information Index Page Page Introduction Diversification Tables Forward-Looking Statements 3 Tenant Diversif

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.